THURSDAY, Aug. 23, 2018 — Oxervate (cenegermin) has been approved by the U.S. Food and Drug Administration to treat neurotrophic […]
- Home
- Neurotrophic
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok